Kestra Advisory Services, LLC Palatin Technologies Inc Transaction History

Kestra Advisory Services, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$0.68 - $1.25 $21,896 - $40,250	-32,200 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$0.38 - $0.78 $2,090 - $4,290	5,500 Added 20.6%	32,200 $23 Million
Q3 2020 Nov 12, 2020	BUY	$0.47 - $0.64 $12,549 - $17,088	26,700 New	26,700 $13 Million

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.3M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.